Table 7 Correlation between the pathological findings and CKα expression.
CKα expression | P-value | |||
|---|---|---|---|---|
0 | 1 | 2 | ||
Invasive component | ||||
Present | 11 (20) | 15 (27) | 22 (39) | 0.001 |
Absent | 7 (13) | 1 (1.8) | 0 (0) | |
Lymphatic invasion | ||||
Present | 13 (23) | 9 (16) | 12 (21) | 0.48 |
Absent | 5 (8.9) | 7 (13) | 10 (18) | |
Histologic grade | ||||
1 | 2 (3.6) | 1 (1.8) | 0 (0) | 0.60 |
2 | 8 (14) | 9 (16) | 12 (21) | |
3 | 8 (14) | 6 (11) | 10 (18) | |
Nuclear grade | ||||
1 | 5 (8.9) | 6 (11) | 4 (7.1) | 0.78 |
2 | 5 (8.9) | 4 (7.1) | 7 (13) | |
3 | 8 (14) | 6 (11) | 11 (20) | |
Nuclear atypia | ||||
1 | 1 (1.8) | 1 (1.8) | 0 (0) | 0.71 |
2 | 9 (16) | 9 (16) | 10 (18) | |
3 | 8 (14) | 6 (11) | 12 (21) | |
Mitosis | ||||
1 | 8 (14) | 12 (21) | 10 (18) | < 0.0001 |
2 | 10 (18) | 1 (1.8) | 0 (0) | |
3 | 0 (0) | 3 (5.4) | 12 (21) | |
Extensive intraductal components | ||||
Present | 9 (16) | 3 (5.4) | 2 (3.6) | 0.01 |
Absent | 9 (16) | 13 (23) | 20 (36) | |
Necrosis | ||||
Present | 8 (14) | 6 (11) | 10 (18) | 0.88 |
Absent | 10 (18) | 10 (18) | 12 (21) | |
Fat invasion | ||||
Present | 7 (13) | 9 (16) | 17 (30) | 0.05 |
Absent | 11 (20) | 7 (13) | 5 (8.9) | |
Cutaneous invasion | ||||
Present | 1 (1.8) | 2 (3.6) | 2 (3.6) | 0.78 |
Absent | 17 (30) | 14 (25) | 20 (36) | |
Muscular invasion | ||||
Present | 1 (1.8) | 1 (1.8) | 0 (0) | 0.51 |
Absent | 17 (30) | 15 (27) | 22 (39) | |
HER-2 receptor | ||||
0 | 7 (13) | 6 (11) | 11 (20) | 0.12 |
1 | 10 (18) | 4 (7.1) | 7 (13) | |
3 | 1 (1.8) | 6 (11) | 4 (7.1) | |
Oestrogen receptor | ||||
Positive | 18 (32) | 10 (18) | 15 (27) | 0.02 |
Negative | 0 (0) | 6 (11) | 7 (13) | |
Progesterone receptor | ||||
Positive | 18 (32) | 11 (20) | 11 (20) | 0.002 |
Negative | 0 (0) | 5 (8.9) | 11 (20) | |
